Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$151.76
▲ $2.26 (+1.51%) today
Markets open · 1:49pm ET

MRK Coverage

Page 71
5:24am ET
Health and Healthcare

Merck (MRK): More Trouble With Vioxx

A lot of people believe that Merck (MRK) knew a lot more about the dangers of its arthritis drug Vioxx than the company ever let on. Heart problems were apparently a by-product…

MRK
Douglas A. McIntyre
8:11am ET
Health and Healthcare

More Blight For Merck (MRK)

Merck (MRK) and Schering-Plough (SGP) make two of the most widely sold drugs in the world. One is cholesterol drug Zetia. Another is a related drug called Vytorin. The sales of the…

MRK
Douglas A. McIntyre
4:20pm ET
Health and Healthcare

Merck Visits The Proctologist (MRK)

Merck & Co. (NYSE: MRK) posted earnings that look pretty good on the surface.  The problem is that the surface is about the only thing that looked appealing for the drug giant…

MRK
Douglas A. McIntyre
1:38pm ET
Health and Healthcare

Long-Term Risks To Statin Sales? (MRK, PFE, AZN)

We have run a full feature story over at BioHealthInvestor.com after reading a study that came off the Mayo Clinic site.  The study showed that a combination of fish oil and red…

Douglas A. McIntyre